Lisinopril and Epitol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lisinopril (lisinopril) and Epitol (carbamazepine). Common drug interactions include cognitive disorder among females and urticaria among males.

The phase IV clinical study analyzes what interactions people have when they take Lisinopril and Epitol. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Lisinopril?

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 358,654 Lisinopril users. Check the latest studies of Lisinopril.

What is Epitol?

Epitol has active ingredients of carbamazepine. It is often used in bipolar disorder. eHealthMe is studying from 397 Epitol users. Check the latest studies of Epitol.



On Jul, 07, 2026

41 people who take Lisinopril and Epitol together, and have interactions are studied.

Lisinopril and Epitol drug interactions.

What are the common drug interactions of Lisinopril and Epitol, by gender? *:

female:

  1. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  2. Confusional state
  3. Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
  4. Depression
  5. Discomfort
  6. Dry mouth
  7. Epistaxis (bleed from the nose)
  8. Eye disorder
  9. Fatigue (feeling of tiredness)
  10. Fibromyalgia (a long-term condition which causes pain all over the body)

male:

  1. Urticaria (rash of round, red welts on the skin that itch intensely)
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Arthralgia (joint pain)
  4. Back pain
  5. Balance disorder
  6. Blindness transient (sudden loss of vision)
  7. Burning sensation
  8. Chest discomfort
  9. Chest pain
  10. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)

What are the common drug interactions of Lisinopril and Epitol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Dry mouth
  2. Epistaxis (bleed from the nose)
  3. Hot flush (sudden feelings of heat)
  4. Hyperhidrosis (abnormally increased sweating)
  5. Libido decreased (loss of interest in sex)
  6. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  7. Rash

30-39:

n/a

40-49:

  1. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  2. Peripheral swelling
  3. Rash
  4. Skin haemorrhage (bleeding into skin)
  5. Temperature intolerance (inability to go in temperature)
  6. Throat irritation
  7. Tinnitus (a ringing in the ears)
  8. Upper respiratory tract infection
  9. Vision blurred
  10. Vomiting

50-59:

  1. Abdominal pain upper
  2. Aphagia (inability or refusal to swallow)
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Dysgraphia (impaired ability to learn to write)
  5. Gait disturbance
  6. Hypersensitivity
  7. Hypokinesia (decreased bodily movement)
  8. Insomnia (sleeplessness)
  9. Abdominal discomfort
  10. Rash

60+:

  1. Weight decreased
  2. Chronic kidney disease
  3. Confusional state
  4. Discomfort
  5. Dizziness
  6. Eye disorder
  7. Fall
  8. Herpes zoster
  9. Injection site extravasation (flow of (blood or lymph) from injection site)
  10. Injection site pain

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 10 people, 24.39%
  2. High Blood Cholesterol: 8 people, 19.51%
  3. Pain: 6 people, 14.63%
  4. Depression: 6 people, 14.63%
  5. Diabetes: 5 people, 12.20%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 9.76%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 9.76%
  8. Stress And Anxiety: 3 people, 7.32%
  9. Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Lisinopril and Epitol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lisinopril and Epitol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lisinopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Epitol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lisinopril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Epitol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lisinopril and carbamazepine (the active ingredients of Lisinopril and Epitol, respectively), and Lisinopril and Epitol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: